Target
Prostaglandin G/H synthase 2
Ligand
BDBM50207448
Substrate
n/a
Meas. Tech.
ChEMBL_461151 (CHEMBL944174)
IC50
100±n/a nM
Citation
 Blobaum, ALMarnett, LJ Structural and functional basis of cyclooxygenase inhibition. J Med Chem 50:1425-41 (2007) [PubMed]  Article 
Target
Name:
Prostaglandin G/H synthase 2
Synonyms:
COX2 | Cyclooxygenase | Cyclooxygenase 2 (COX-2) | Cyclooxygenase-2 | Cyclooxygenase-2 (COX-2 AA) | Cyclooxygenase-2 (COX-2 AEA) | Cyclooxygenase-2 (COX-2) | PGH synthase 2 | PGH2_HUMAN | PGHS-2 | PHS II | PTGS2 | Prostaglandin E synthase/G/H synthase 2 | Prostaglandin H2 synthase 2 | Prostaglandin-endoperoxide synthase 2
Type:
Enzyme
Mol. Mass.:
69003.89
Organism:
Homo sapiens (Human)
Description:
Recombinant Cox-2 provided by Cayman (Cayman Chemical Co.,Ann Arbor, MI).
Residue:
604
Sequence:
MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL
  
Inhibitor
Name:
BDBM50207448
Synonyms:
2-(2',6'-diethoxy-2-fluoro-biphenyl4-yl)-propionic acid | CHEMBL257539
Type:
Small organic molecule
Emp. Form.:
C19H21FO4
Mol. Mass.:
332.366
SMILES:
CCOc1cccc(OCC)c1-c1ccc(cc1F)C(C)C(O)=O |w:19.21,(26.76,-25.54,;28.1,-24.77,;29.43,-25.54,;30.76,-24.77,;30.77,-23.22,;32.1,-22.45,;33.43,-23.22,;33.44,-24.77,;34.77,-25.54,;36.1,-24.76,;37.44,-25.53,;32.1,-25.54,;32.1,-27.08,;30.76,-27.84,;30.76,-29.38,;32.1,-30.15,;33.44,-29.38,;33.43,-27.84,;34.76,-27.07,;32.1,-31.69,;30.77,-32.47,;33.43,-32.46,;33.44,-34.01,;34.77,-31.69,)|
Structure:
Search PDB for entries with ligand similarity: